Adial Pharmaceuticals, Inc (ADIL) Social Stream
ADIAL PHARMACEUTICALS INC (ADIL) Price Targets From Analysts
Use the tables below to see what analysts covering ADIAL PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ADIL's average price target has moved up $3.5 over the prior 17 months.
Over the past 41 weeks, ADIL's average upside potential has been 1,296.61%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ADIL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ADIL's average broker recommendation rating worsened by 0.67 over the prior 24 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADIL as an investment opportunity.
- In the context of all US stocks, ADIAL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 893.22% of them.
- ADIAL PHARMACEUTICALS INC's number of analysts covering the stock is greater than 74.88% of all US stocks.
- ADIAL PHARMACEUTICALS INC's average analyst price target is higher than 153.17% of Healthcare stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, ADIAL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -364.53% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADIAL PHARMACEUTICALS INC are XCUR, IMV, and ASLN.
What is the outlook for ADIL? Use POWR Ratings for clearer insight into price direction.